The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness
Open accessAbstract
Phospholipase D (PLD) is an essential enzyme responsible for the production of the lipid second messenger phosphatidic acid. Phosphatidic acid participates in both G protein-coupled receptor and receptor tyrosine kinase signal transduction networks. The lack of potent and isoform-selective inhibitors has limited progress in defining the cellular roles of PLD. We used a diversity-oriented synthetic approach and developed a library of PLD inhibitors with considerable pharmacological characterization. Here we report the rigorous evaluation of that library, which contains highly potent inhibitors, including the first isoform-selective PLD inhibitors. Specific members of this series inhibit isoforms with > 100-fold selectivity both in vitro and in cells. A subset of inhibitors was shown to block invasiveness in metastatic breast cancer models. These findings demonstrate the power of diversity-oriented synthesis combined with biochemical assays and mass spectrometric lipid profiling of cellular responses to develop the first isoform-selective PLD inhibitors—a new class of antimetastatic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guy, C. T., Cardiff, R. D., & Muller, W. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.954 · Cited by 1,631
Wymann, M. P., & Schneiter, R. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2335 · Cited by 1,291
Phosphatidic Acid-Mediated Mitogenic Activation of mTOR Signaling
Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A., & Chen, J. (2001) · Science · doi:10.1126/science.1066015 · Cited by 1,055
Brown, H. A., Gutowski, S., Moomaw, C. R., Slaughter, C., & Sternwels, P. C. (1993) · Cell · doi:10.1016/0092-8674(93)90323-i · Cited by 901
Self-citationColley, W. C., Sung, T.-C., Roll, R., Jenco, J., Hammond, S. M., Altshuller, Y., Bar-Sagi, D., Morris, A. J., & Frohman, M. A. (1997) · Current Biology · doi:10.1016/s0960-9822(97)70090-3 · Cited by 698
Hammond, S. M., Altshuller, Y. M., Sung, T.-C., Rudge, S. A., Rose, K., Engebrecht, J., Morris, A. J., & Frohman, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29640 · Cited by 658
Ktistakis, N. T., Brown, H. A., Waters, M. G., Sternweis, P. C., & Roth, M. G. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.2.295 · Cited by 378
Self-citationPonting, C. P., & Kerr, I. D. (1996) · Protein Science · doi:10.1002/pro.5560050513 · Cited by 328
Rizzo, M. A., Shome, K., Vasudevan, C., Stolz, D. B., Sung, T.-C., Frohman, M. A., Watkins, S. C., & Romero, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.1131 · Cited by 297
Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos
Zhao, C., Du, G., Skowronek, K., Frohman, M. A., & Bar-Sagi, D. (2007) · Nature Cell Biology · doi:10.1038/ncb1594 · Cited by 293
Exton, J. H. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03405-1 · Cited by 260
Regulation of Phospholipase D in HL-60 Granulocytes
Billah, M. M., Pai, J.-K., Mullmann, T. J., et al. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81903-2 · Cited by 250
Phospholipase D confers rapamycin resistance in human breast cancer cells
Chen, Y., Zheng, Y., & Foster, D. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206565 · Cited by 196
Kato, Y., Lambert, C. A., Colige, A. C., Mineur, P., Noël, A., Frankenne, F., Foidart, J.-M., Baba, M., Hata, R.-I., Miyazaki, K., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411313200 · Cited by 182
Imamura, F., Horai, T., Mukai, M., Shinkai, K., Sawada, M., & Akedo, H. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1651 · Cited by 180
Bi, K., Roth, M. G., & Ktistakis, N. T. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00153-9 · Cited by 178
Overexpression of phospholipase D1 in human breast cancer tissues
Noh, D. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00612-1 · Cited by 166
Cloning and Characterization of Phospholipase D from Rat Brain
Park, S., Provost, J. J., Bae, C. D., Ho, W., & Exton, J. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.29263 · Cited by 138
Increased Activity and Intranuclear Expression of Phospholipase D2 in Human Renal Cancer
Zhao, Y., Ehara, H., Akao, Y., Shamoto, M., Nakagawa, Y., Banno, Y., Deguchi, T., Ohishi, N., Yagi, K., & Nozawa, Y. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3719 · Cited by 137
Ca2 +‐mobilizing hormones elicit phosphatidylethanol accumulation via phospholipase D activation
Bocckino, S. B., Wilson, P. B., & Exton, J. H. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81157-2 · Cited by 129
Optimization of Halopemide for Phospholipase D2 inhibition
Monovich, L. G., Mugrage, B. B., Quadros, E., Toscano, K., Tommasi, R., LaVoie, S., Liu, E. W., Du, Z., LaSala, D., Boyar, W. C., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.01.059 · Cited by 102
Role of phospholipase D in laminin-induced production of gelatinase A (MMP-2) in metastatic cells
Reich, R., Blumenthal, M., & Liscovitch, M. (1995) · Clinical & Experimental Metastasis · doi:10.1007/bf00133618 · Cited by 93
Biochemical Analysis of Phospholipase D
Brown, H. A., Henage, L. G., Preininger, A. M., Xiang, Y., & Exton, J. H. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)34004-4 · Cited by 91
Self-citationIncreased phospholipase D activity in human breast cancer
Uchida, N., Okamura, S.-I., Nagamachi, Y., & Yamashita, S. (1997) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01208639 · Cited by 87
Min, D. S. (2001) · Carcinogenesis · doi:10.1093/carcin/22.10.1641 · Cited by 78
Garcia, A., Yang, Z., Zhao, C., Toschi, A., Fan, J., Shraibman, N., Brown, H. A., Bar‐Sagi, D., Foster, D. A., & Arbiser, J. L. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0102 · Cited by 78
Self-citationKinetic Analysis of a Mammalian Phospholipase D
Henage, L. G., Exton, J. H., & Brown, H. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508800200 · Cited by 75
Self-citationAssociation of N- and C-terminal Domains of Phospholipase D Is Required for Catalytic Activity
Zhi, X., Ho, W., & Exton, J. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.34679 · Cited by 73
Kang, D. W., Park, M. H., Lee, Y. J., Kim, H. S., Kwon, T. K., Park, W.-S., & Min, D. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707416200 · Cited by 71
Association of a polymorphism of the phospholipase D2 gene with the prevalence of colorectal cancer
Yamada, Y., Hamajima, N., Kato, T., Iwata, H., Yamamura, Y., Shinoda, M., Suyama, M., Mitsudomi, T., Tajima, K., Kusakabe, S., et al. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0411-x · Cited by 69
Requirement of phospholipase D1 activity in H-Ras V12 -induced transformation
Buchanan, F. G., McReynolds, M., Couvillon, A. D., Kam, Y., Holla, V. R., DuBois, R. N., & Exton, J. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406698102 · Cited by 67
Wang, L., Cummings, R. J., Usatyuk, P. V., Morris, A. J., Irani, K., & Natarajan, V. (2002) · Biochemical Journal · doi:10.1042/bj20020586 · Cited by 63
Eisen, S. F., & Brown, H. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.4.911 · Cited by 39
Self-citationLevy, B. D., Hickey, L., Morris, A. J., Larvie, M., Keledjian, R., Petasis, N. A., Bannenberg, G. L., & Serhan, C. N. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706338 · Cited by 35
Hancock, J. F. (2007) · Nature Cell Biology · doi:10.1038/ncb0607-615 · Cited by 32
Phospholipase D2 stimulates cell protrusion in v-Src-transformed cells
Shen, Y., Yang, Z., & Foster, D. A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00204-8 · Cited by 32
Tou, J., & Urbizo, C. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00137-1 · Cited by 26
Tou, J., & Urbizo, C. (2007) · Steroids · doi:10.1016/j.steroids.2007.10.002 · Cited by 14
Cited by
Astrocytes mediate neurovascular signaling to capillary pericytes but not to arterioles
Mishra, A., Reynolds, J. P., Chen, Y., Gourine, A. V., Rusakov, D. A., & Attwell, D. (2016) · Nature Neuroscience · doi:10.1038/nn.4428 · Cited by 543
Exosomes as intercellular signalosomes and pharmacological effectors
Record, M., Subra, C., Silvente-Poirot, S., & Poirot, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.02.011 · Cited by 537
Phospholipase D: Enzymology, Functionality, and Chemical Modulation
Selvy, P. E., Lavieri, R. R., Lindsley, C. W., & Brown, H. A. (2011) · Chemical Reviews · doi:10.1021/cr200296t · Cited by 389
Self-citationManganese-Based Nanoactivator Optimizes Cancer Immunotherapy via Enhancing Innate Immunity
Hou, L., Tian, C., Yan, Y., Zhang, L., Zhang, H., & Zhang, Z. (2020) · ACS Nano · doi:10.1021/acsnano.9b06111 · Cited by 309
Teasdale, R. D., & Collins, B. M. (2012) · Biochemical Journal · doi:10.1042/bj20111226 · Cited by 281
Metadata
- Authors
- Scott, S. A., Selvy, P. E., Buck, J. R., Cho, H. P., Criswell, T. L., Thomas, A. L., Armstrong, M. D., Arteaga, C. L., Lindsley, C. W., & Brown, H. A.
- Venue
- Nature Chemical Biology
- Published
- 2009-01-11
- Volume
- 5
- Issue
- 2
- Pages
- 108-117
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W1967305117
- Cited by
- 280
- References
- 38
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.